Continuing Medical Education: Pharmaceutical CME: Continuing Education Inc.: Update on Indications, Interactions and Complications in the Use of Pharmaceuticals: Cruise Conference CME: April 11 - 18, 2009
http://www.cmenetworks.com/cme/9718/1/Continuing-Medical-Education-Pharmaceutical-CME-Continuing-Education-Inc-Update-on-Indications-Interactions-and-Complications-in-the-Use-of-Pharmaceuticals-Cruise-Conference-CME-April-11---18-2009/Page1.html
Continuing Education, Inc.
Continuing Education Inc. is committed to developing and presenting the finest accredited continuing education programs for professionals that can be found. Our programs cover a wide range of disciplines including Medicine, Dentistry, Law, Accountancy, Insurance, Finance, Architecture, Engineering, and others.
These programs are designed for the specific purpose of allowing the busy professional to obtain the educational course credits required to maintain licensure, while at the same time enjoying a family holiday without spending too much time away from his or her practice.
By Continuing Education, Inc.
Published on 09/2/2008
Update on Indications, Interactions and Complications in the Use of Pharmaceuticals
Continuing Education Inc.
April 11 - 18, 2009
Hawaiian Islands Cruise Conference from Honolulu
Continuing Education Inc.
April 11 - 18, 2009
Hawaiian Islands Cruise Conference from Honolulu
Update on Indications, Interactions and Complications in the Use of Pharmaceuticals
CME Sponsor:
Continuing Education Inc.
Location:
Hawaiian Islands Cruise from Honolulu
Course Directors/Instructors:
George E. Mackinnon, PhD., RPh.
Karen Mackinnon, RPh
Course Fee:
Physicians $695
All Others $450
Number of Credits:
14 Category 1 CME Credits
14 Contact Hours
Link
Contact
Detailed Description:
After attending the following session individuals should be able to:
Location:
Hawaiian Islands Cruise from Honolulu
Course Directors/Instructors:
George E. Mackinnon, PhD., RPh.
Karen Mackinnon, RPh
Course Fee:
Physicians $695
All Others $450
Number of Credits:
14 Category 1 CME Credits
14 Contact Hours
Link
Contact
Detailed Description:
After attending the following session individuals should be able to:
- Outline strategies for assessing and counseling patients on the use of OTC products.
- Describe patients attitude about monitoring and diagnostics for self-care.
- Explain issues related to drug safety, patient information, and other recent FDA activities such as prescription drug labeling, MedWatch, and post-marketing safety surveillance.
- Describe the mechanism of action and indications for newly approved drugs.
- Identify challenges and safety concerns regarding the medication approval and post-market surveillance processes.
- Describe the necessary points within the medication use system in which technology can be employed to reduce medical errors within health care.
- Describe the benefits and limitations of collaborative practice models in various patient care settings.